Burges Salmon’s Healthcare team has worked with the Department for Business, Energy and Industrial Strategy (BEIS) to secure an important part of the UK’s response to COVID-19, striking an agreement for manufacturing capacity at Wockhardt’s facility in Wrexham to provide fill finish services for COVID-19 vaccines. The agreement was signed on 31 July 2020.
The agreement allows the UK government to call upon fill finish capacity to support a variety of vaccine programmes.
The Secretary of State for Business, Energy and Industrial Strategy, Alok Sharma said: “Ensuring the UK has the capability to research, develop and manufacture a safe and effective vaccine is critical in our fight against coronavirus. Today we have secured additional capacity to manufacture millions of doses of multiple Covid-19 candidates, guaranteeing the supply of vaccines we need to protect people across the UK rapidly and in large numbers.”
The Burges Salmon team was led by partner Patrick Parkin, with support from director Rory Trust, associate Antonia Venning, partner John Houlden and senior associates Punim Anda and Sam Charkham.
Patrick says: “Burges Salmon is delighted to have supported the team at BEIS and the HMG Vaccines Taskforce.”